MKRN9P

Across TCGA pan-cancer cohorts, MKRN9P RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated MKRN9P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MKRN9P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MKRN9P expression acts as an unfavorable survival marker, although some lineages such as MESO and ACC show a favorable association.

KIRC, LUAD, and KIRP are the cancer types where MKRN9P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.748	0.855	<.001	60	view →
LUAD	OS	Tertile	II,III,IV	0.613	0.797	.002	41	view →
KIRP	DFS	Median	II,III,IV	0.501	0.937	.006	36	view →
MESO	DFS	Quartile	III,IV	0.567	0.287	.009	21	view →
ACC	OS	Median	IV	0.800	0.303	.001	19	view →
STAD	DFS	Median	II,III,IV	0.433	0.603	.006	18	view →
LIHC	DFS	Tertile	All	0.430	0.562	.009	13	view →
LGG	OS	Median	All	0.749	0.850	.004	11	view →
ESCA	DFS	Tertile	All	0.409	0.593	.011	10	view →
THCA	DFS	Median	III,IV	0.772	0.933	.008	8	view →
PCPG	DFS	Median	All	1.000	0.708	.006	8	view →
PRAD	DFS	Tertile	All	0.926	0.860	.033	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

MKRN9P–KIRC (DFS)

Open the KIRC breakdown →